ABPI Final Signatory Support

Contractor or fully outsourced signatory cover to keep approvals moving, strengthen claims, and reduce PMCPA risk—without slowing the business.

  • Same-day / next-day review options (by agreement)

  • Evidence-led claim strengthening (not just “red pen” edits)

  • Practical support for job bags, meetings, congress and digital

Led by Dr Anzal Qurbain — ABPI Final Medical Signatory • GMC Registered Pharmaceutical Physician • MBA (LBS) • FFPM

What this support delivers

Clearer decisions, faster cycles, stronger rationale—without losing commercial impact.

Who is this for?

For teams that want signatory-ready output at pace.

  • Busy brand teams
  • Medical/compliance teams under capacity pressure
  • Launch/campaign and congress teams
  • Digital + PR owners
  • UK/ROI teams needing ABPI signatory cover

How it works

Choose the model that fits your team and workload.

Each week combines bite-sized learning with real-world application—so you strengthen compliant decision-making, reduce rework, and feel confident defending claims across job bags, meetings, and digital content.

Embedded Contractor Final Signatory

I join your approval workflow as a contracted Final Signatory to support business-as-usual approvals and peak periods (congresses, launches, capacity gaps, leave cover).

• Day-to-day signatory documented
• Live collaboration with originators/reviewers
• Escalation support for difficult claim areas

Outsourced Signatory + Copy Review Service

A structured outsourced model for teams that want reliable turnaround, consistent standards, and an external signatory/advisory layer for materials. (This is the “outsourced approval + advisory” style used by established providers in the market.)

• Defined intake, triage and review pathway
• Clear outputs: approve / approve with changes
• Optional advisory sessions to unblock issues fast

Typical materials reviewed

  • Core visual aids
  • Leave pieces, emails, banners, landing pages
  • Meetings & congress materials (including international congress content)
  • Advisory board materials (invites, agendas, slides, outputs)
  • Press releases and corporate announcements
  • Patient-facing / public comms (where appropriate)
  • Internal training and field tools (including REP support)

FAQ

Frequently Asked Questions

Embedded support integrates into your day-to-day approval process as a contracted Final Signatory. Outsourced support uses a defined intake/review pathway for materials, giving you predictable turnaround and consistent outputs across teams.

This depends on volume and complexity. We can agree standard turnaround (e.g., 24–72 hours) plus an expedited pathway for priority materials during peak periods.

Both. The goal is compliant and effective. I’ll help tighten claim logic, improve balance, and make materials more approvable—without unnecessary de-powering.

Typically: digital/social ecosystems, press releases, high-impact claims (superiority/first & only), public-facing content, and meeting materials where hospitality/governance wording is unclear.

Yes—especially where UK ABPI standards need to be applied consistently alongside global content and local requirements.

I provide concise rationale notes and repeatable standards so decisions are consistent across teams, topics, and timelines—reducing rework and internal debate.

Yes. If helpful, we can add short enablement sessions to reduce future cycles—e.g., “what good looks like” for claims, job bags, meetings, and digital.

Book a call. Share your typical materials, workflow, volume, and timelines. I’ll propose the best support model and a simple onboarding plan.

Insights and more

News & PMCPA Cases

Insights
Anzal Qurbain

Blurred boundaries: Lessons from the Eli Lilly Facebook Breast Cancer Ad (CASE/3869/12/23)

TL;DR: Even a globally reputable company using trusted partners can stumble into serious compliance breaches online. All pharma professionals should be proactive, transparent, and vigilant—especially with third-party digital campaigns. The future of ethical pharmaceutical advertising depends on it. For many in pharma, the digital landscape can feel like quicksand—seemingly solid

Read More »
Insights
Anzal Qurbain

LinkedIn landmines: The hidden pitfalls of pharma social media

What 214 Social Media cases taught me about compliance risk I’ve just finished reviewing 214 PMCPA cases where social media played a role. The pattern is undeniable: LinkedIn and other platforms are now a leading source of ABPI Code breaches. And the worrying part? Most of these breaches started with

Read More »